A detailed history of Yousif Capital Management, LLC transactions in Dexcom Inc stock. As of the latest transaction made, Yousif Capital Management, LLC holds 57,678 shares of DXCM stock, worth $4.34 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
57,678
Previous 57,770 0.16%
Holding current value
$4.34 Million
Previous $6.55 Million 40.98%
% of portfolio
0.04%
Previous 0.08%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024

SELL
$64.0 - $116.06 $5,888 - $10,677
-92 Reduced 0.16%
57,678 $3.87 Million
Q2 2024

Jul 31, 2024

BUY
$110.31 - $140.45 $9,707 - $12,359
88 Added 0.15%
57,770 $6.55 Million
Q1 2024

Apr 26, 2024

SELL
$114.22 - $140.1 $158,651 - $194,598
-1,389 Reduced 2.35%
57,682 $8 Million
Q4 2023

Feb 01, 2024

SELL
$75.49 - $124.16 $588,746 - $968,323
-7,799 Reduced 11.66%
59,071 $7.33 Million
Q3 2023

Oct 30, 2023

SELL
$86.06 - $137.93 $93,633 - $150,067
-1,088 Reduced 1.6%
66,870 $6.24 Million
Q2 2023

Aug 02, 2023

BUY
$112.47 - $130.98 $220,666 - $256,982
1,962 Added 2.97%
67,958 $8.73 Million
Q1 2023

May 02, 2023

SELL
$104.0 - $122.92 $29,432 - $34,786
-283 Reduced 0.43%
65,996 $7.67 Million
Q4 2022

Jan 09, 2023

SELL
$84.98 - $122.67 $1.02 Million - $1.47 Million
-11,951 Reduced 15.28%
66,279 $0
Q3 2022

Nov 04, 2022

SELL
$76.35 - $94.18 $103,835 - $128,084
-1,360 Reduced 1.71%
78,230 $6.3 Million
Q2 2022

Aug 01, 2022

BUY
$67.99 - $132.89 $4.1 Million - $8.02 Million
60,333 Added 313.3%
79,590 $5.93 Million
Q1 2022

May 12, 2022

BUY
$94.08 - $130.2 $34,339 - $47,522
365 Added 1.93%
19,257 $9.85 Million
Q4 2021

Jan 31, 2022

BUY
$129.87 - $162.82 $2.45 Million - $3.08 Million
18,892 New
18,892 $10.1 Million

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $29.1B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Yousif Capital Management, LLC Portfolio

Follow Yousif Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Yousif Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Yousif Capital Management, LLC with notifications on news.